TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence

Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence: an Open-label Randomized Controlled Trial: TRAPIST - TRAP Intervention STudy

NCT02621645•Universitaire Ziekenhuizen KU Leuven

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Twin Reversal Arterial Perfusion Syndrome

Interventions

Early selective reduction of TRAP mass

Late selective reduction of TRAP mass

+3 more

Locations

United States

Locations (14)

Children's Memorial Hermann Hospital

Houston, Texas, United States

Universitätsklinik für Frauenheilkunde und Geburtshilfe

Graz, Austria

Universitaire Ziekenhuizen Leuven

Leuven, Belgium

Mount Sinai Hospital

Toronto, Canada

Centre Médico-Chirurgical et Obstétrical

Schiltigheim, France

Universitätsklinikum Hamburg-Eppendorf

Hamburg, Germany

Key Dates

Start Date

May 1, 2016

Primary Completion Date

June 1, 2025

Completion Date

June 1, 2025

Last Updated

July 10, 2024

Contacts

Isabel Couck, MD

CONTACT

+32 16 342294 isabel.couck@uzleuven.be

Liesbeth Lewi, MD PhD

CONTACT

+32 16 342862 liesbeth.lewi@uzleuven.be

Sponsors

Lead Sponsor

Universitaire Ziekenhuizen KU Leuven

Collaborators

St. George's Hospital, University of London (UK sponsor)
Leiden University Medical Center
Ospedalo Maggiore Policlinico di Milano, Italy
Hospital Universitari Vall d'hebron Barcelona, Spain
Centro Médico-Chirurgical et Obstétrical (CMCO) Schiltigheim, France
Universitätsklinik für Frauenheilkunde und Geburtshilfe Graz, Austria
Ospedale dei Bambini "Vittore Buzzi" Milano, Italy
Birmingham Women's Hospital, UK
Sheba Medical Center
Children's Memorial Hermann Hospital Houston Texas, USA
Universitätsklinikum Hamburg-Eppendorf, Germany
Mount Sinai Hospital, Canada
University of Pittsburgh
University Hospital Innsbruck, Austria
Spedali Civili, University of Brescia, Italy

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 10, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions